{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:02:35Z","timestamp":1791140555748,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold>Neutropenia, a major side\u2010effect of interferon\u2010\u03b1 (IFN\u2010\u03b1) therapy can be effectively treated by the recombinant form of granulocyte colony stimulating factor (G\u2010CSF), an important growth factor for neutrophils. We hypothesized that IFN\u2010\u03b1 might suppress G\u2010CSF production by peripheral blood mononuclear cells (PBMCs), contributing to the development of neutropenia, and that a toll\u2010like receptor (TLR) agonist might overcome this suppression.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Fifty\u2010five patients who were receiving IFN\u2010\u03b1\/ribavirin combination therapy for chronic hepatitis C virus (HCV) infection were recruited. Absolute neutrophil counts (ANC), monocyte counts and treatment outcome data were recorded. G\u2010CSF levels in the supernatants of PBMCs isolated from the patients and healthy controls were assessed by enzyme\u2010linked immunosorbent assay following 18\u2003h of culture in the absence or presence of IFN\u2010 \u03b1 or the TLR7\/8 agonist, CL097.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Therapeutic IFN\u2010\u03b1 caused a significant reduction in neutrophil counts in all patients, with 15 patients requiring therapeutic G\u2010CSF. The reduction in ANC over the course of IFN\u2010\u03b1 treatment was paralleled by a decrease in the ability of PBMCs to produce G\u2010CSF.<jats:italic>In vitro<\/jats:italic>G\u2010CSF production by PBMCs was suppressed in the presence of IFN\u2010\u03b1; however, co\u2010incubation with a TLR7\/8 agonist significantly enhanced G\u2010CSF secretion by cells obtained both from HCV patients and healthy controls.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>Suppressed G\u2010CSF production in the presence of IFN\u2010\u03b1 may contribute to IFN\u2010\u03b1\u2010induced neutropenia. However, a TLR7\/8 agonist elicits G\u2010CSF secretion even in the presence of IFN\u2010\u03b1, suggesting a possible therapeutic role for TLR agonists in treatment of IFN\u2010\u03b1\u2010induced neutropenia.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2010.06281.x","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T11:39:49Z","timestamp":1265197189000},"page":"1883-1890","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interferon\u2010\u03b1 suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7\/8 agonist"],"prefix":"10.1111","volume":"25","author":[{"given":"Tariq","family":"Tajuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Hegarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona","family":"O'Farrelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03055.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried MW","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34175"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00394-9"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V70.4.1173.1173","article-title":"Effect of recombinant interferons alpha and gamma on human bone marrow\u2010derived megakaryocytic progenitor cells","volume":"70","author":"Ganser A","year":"1987","journal-title":"Blood"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/135965350601100514","article-title":"Defective synthesis of granulocyte\u2010colony stimulating factor in pegylated interferon\u2010alpha treated chronic hepatitis C patients with declining leukocyte counts","volume":"11","author":"Durante\u2010Mangoni E","year":"2006","journal-title":"Antivir. Ther."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03089.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000142583.00102.45"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00870.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0032323"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1112"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1589"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-216770"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210913"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.6.1737.1737"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.03.002"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-139923"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02335-5"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22964"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.02.035"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-048686"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.03.005"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.04.006"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(01)00022-3"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.03.509"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324651"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03799.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.08.015"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.863"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.7.3385"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2008.21.2.1188193"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.07.011"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(95)00054-P"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2010.06281.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2010.06281.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:43:10Z","timestamp":1739781790000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2010.06281.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1440-1746.2010.06281.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06281.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]},"assertion":[{"value":"2010-11-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}